Background
TRPS1 transcription factor, the only known atypical member of GATA transcriptional factor family, contains a GATA DNA binding domain like other typical GATAs 1–6 [
1]. TRPS1 is important both in development and in carcinogenesis. Mutations in TRPS1 have been documented to cause tricho-rhino-phalangeal syndrome, an autosomal-dominant disorder characterized by craniofacial and skeletal malformations [
2]. Elevated TRPS1 expression has been observed in human cancers, including osteosarcoma [
3], colon cancer [
4], and breast cancer [
5]. Recently,
TRPS1 was identified by in vivo transposon-based forward genetic screening as a potential breast cancer driver gene by our group and others [
6,
7]. However, the mechanism by which TRPS1 contributes to cancer is not clear.
Histone deacetylases (HDACs) and histone acetyltranferases (HATs) are important in acetylation of histones and non-histone substrates to control and maintain a balance in the transcriptomic landscape of the normal and tumor cells [
8‐
10]. HDACs regulate the expression and activity of numerous proteins involved in both cancer initiation and progression [
10]. Eighteen mammalian HDACs have been identified and divided into four classes based on phylogenetic analysis and homology to
Saccharomyces cerevisiae HDACs [
11]. HDAC2, a member of the mammalian class I deacetylases, has been extensively studied. A decrease in HDAC2 markedly inhibits tumor growth, suggesting HDAC2 acts as an oncogene in tumorigenesis [
12,
13]. Overexpression of HDAC2 protein was detected in human cancers, including gastric, prostate, and breast cancers [
14,
15]. HDAC2 represses gene expression via deacetylating H4K16ac [
16], determines the transcription repression program, and acts as a member of nucleosome remodeling deacetylase (NURD) complex [
17].
The ubiquitin system plays a significant role in determining the fate of a protein. De-ubiquitinases (DUBs) also have fundamental roles in the ubiquitin system through deconjugating ubiquitin from the targeted proteins [
18]. The ubiquitin-specific peptidase 4 (USP4) is proposed to be a potential oncogene, which can transform NIH3T3 cells [
19], and USP4-deficient murine embryonic fibroblasts exhibit retarded growth [
20]. Previous studies indicate that, compared to normal cells, USP4 is overexpressed in malignant cells [
21]. Recently, USP4 was reported to de-ubiquitinate and stabilize HDAC2, which then inhibits p53 and NF-kB [
22]. However, the mechanism by which USP4 mediates HDAC2 de-ubiquitination contributing to cancer remains unclear.
In this study, we show that the TRPS1-USP4-HDAC2 regulatory axis is involved in tumor cell proliferation. We provide a novel mechanistic insight into the growth-regulatory role of this axis by providing evidence that TRPS1 recruits USP4 to de-ubiquitinate and stabilize HDAC2. We also illustrate the scaffolding function of TRPS1 as the first example of the non-transcription factor function of GATA transcription factor which affects the ubiquitination and transcription repressive function of HDAC2, acetylation of H4K16, and the de-ubiquitinase function of USP4.
Methods
Cell culture
T47D, BT474, MCF7, MDA-MB-231, and HEK293T cell lines were purchased from American Type Culture Collection (ATCC) and were authenticated by the short tandem repeat (STR) typing. The cell lines were used for the current study within 6 months after cell authentication. BT474 and HEK293T cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) (HyClone, NY, USA) and 1% penicillin-streptomycin solution (Life Technologies). T47D and MCF7 were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium (Corning Cellgro) supplemented with 10% FBS and 1% penicillin-streptomycin solution. To generate TRPS1 overexpression system in MDA-MB-231, the open reading frame (ORF) of TRPS1 was cloned into the lentivirus vector pCDH-CMV-MCS-EF1-copGFP (System Bioscience, CA, USA) and then transfected into HEK293T cells. The virus-containing supernatant was collected 48 h after transfection, and passed through the 0.45 μm filter to infect MDA-MB-231 cells.
Plasmids
The following plasmids were used in this study: pCDNA3.1-Flag-USP4, pCDNA3.1-Myc-HDAC2, pCDNA3.1-His-Ub, p3 × Flag-TRPS1, p3 × Flag-TRPS1-N(1–2640), p3 × Flag-TRPS1-ΔC(1–2940), p3 × Flag-TRPS1-C(2941–3885), p3 × Flag-TRPS1-ΔN(2641–3885), p3 × Flag-TRPS1-GATA(2641–2940), 4 × UAS-TK-luciferase, GAL4-HDAC2, and Renilla luciferase (pRL-SV40).
Antibodies
Antibodies used in this study and their sources are as follows: anti-TRPS1 (R&D Systems#AF4838), anti-HDAC2 (Cell Signaling Technology#5113), anti-H4K16ac (Millipore#39929), anti-H4 (Millipore#04–858), anti-USP4 (Cell Signaling Technology#2651), anti-actin (proteintech#60008–1-Ig), anti-HA (Biotool#B23402), anti-Flag (Sigma#F7425), anti-Myc (Biotool#B23402), anti-His (Cell Signaling Technology#12698), and anti-Gal4 (Santa Cruz#510).
Immunoprecipitation and immunoblotting
Cells were collected and lysed for 15 min on ice in the lysis buffer (Beyotime) supplemented with a protease inhibitor. The cell lysates were incubated with antibodies and protein A/G agarose overnight at 4 °C. Unbound proteins were removed by washing three times with wash buffer. The immunoprecipitates from agarose beads were removed using the elution buffer (50 mM Tris–HCl (pH 7.4), 900 mM NaCl, 1 mM EDTA, 1% Triton X-100) for sequential co-immunoprecipitation (Co-IP). For immunoblotting following SDS-PAGE, immunoprecipitated proteins were transferred to polyvinylidene fluoride (PVDF) membranes (Millipore) and probed with various antibodies. The ECL detection system (ImageQuant LAS4000) was used for detection.
Ubiquitination assay
To examine the ubiquitin-modified proteins, cells were lysed in the denaturing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 4%SDS, 1 mM EDTA, 8% glycerol, 1 mM DTT, 1 mM PMSF and protein inhibitors) supplemented with 20 mM NEM and heated at 90 °C for 10 min. For immunoprecipitation, the lysates were further diluted to 0.1% SDS and immunoprecipitated with anti-Myc antibody at 4 °C overnight and then the ubiquitinated proteins were tested by western blotting.
RT-qPCR analysis
For RT-qPCR analysis, total RNAs were extracted from various cell lines using the RNeasy kit (Qiagen, Hilden, Germany) and reverse transcription of RNA was performed using PrimeScript RT reagent kit (TaKaRa, Otsu, Shiga, Japan) according to the manufacturer’s instructions. The primers used for RT-qPCR are listed in Additional file
1: Table S1.
RNA interference (RNAi)
Small interfering RNAs (siRNAs) targeting TRPS1, HDAC2, USP4 or the non-targeting control siRNA (Genepharm, Shanghai, China) were transfected into MCF7, BT474, and T47D cells using Lipofectamine RNAi MAX (Invitrogen; Carlsbad, CA, USA) according to the manufacturer’s instructions. All plasmids were transfected using Lipofectamine®2000 (Invitrogen; Carlsbad, CA, USA). An MCF7 cell line with stable depletion of TRPS1 was generated using a lentivirus short hairpin RNA (shRNA) system. The sequences for siRNAs and shRNA are listed in Additional file
2: Table S2.
Luciferase reporter assay
HEK-293 T cells were transfected with 4 × UAS-TK-luc, Gal4-HDAC2, pRL-SV40, and Flag-TRPS1/truncations or control vector as indicated. Cells were subjected to luciferase reporter assay according to instructions provided in the Promega dual luciferase reporter assay kit.
Cell proliferation assay
Cell proliferation was measured using the CCK-8 kit according to the protocol recommended by the manufacturer (Dojindo Laboratories, Kumamoto, Japan). Cells were seeded into 96-well plates. After treatment with siRNA, cells were grown for 24 h or 48 h. Absorbance was read at 450 nm using a Bio-Rad iMark plate reader.
RNA-sequencing (RNA-Seq) analysis
MCF7 cells were transfected with non-targeting siRNAs (control siRNAs), TRPS1 siRNAs, and HDAC2 siRNAs. At 48 h later, total RNA was extracted from the same number of cells from each group with the RNeasy kit (OMEGA). Analysis of RNA-Seq data was performed using a standard TopHat-Cufflinks workflow.
ChIP-qPCR
Formaldehyde was added to the cell culture medium at a final concentration of 1%, then incubated at room temperature (RT) with shaking to create protein-DNA crosslinks. After 10 min, glycine was added to the cell culture medium to stop fixation. Subsequently, the cells were washed with ice-cold PBS, harvested in SDS lysis buffer containing the protease inhibitor, and sheared by sonication. Sheared chromatin was used for immunoprecipitation with IgG and anti-H4K14Ac antibodies. The immunoprecipitates were washed, reverse crosslinked, and eluted to obtain the purified DNA for q-PCR. Primer sequences used for ChIP-qPCR experiments are listed in Additional file
1: Table S1.
Tumor xenografts
Four-to-six-week-old female athymic nude (Foxn/nu/nu) mice were purchased from the Model Animal Research Center of Nanjing University. MCF-7 cells (5 × 106) suspended in 200 μl of the PBS–Matrigel mixture were injected into the mammary fat pads. A 0.72-mg E2 60-day release pellet (Innovative Research of America, Sarasota, FL, USA) was implanted subcutaneously on the dorsal side of each mouse a day before tumor cells injection. The length and width of tumors were examined weekly using a Vernier caliper and the volume was calculated by the formula:
π/6 × length×width2.
Discussion
In this study, we report that TRPS1, USP4, and HDAC2 form a regulatory axis to confer tumor growth. TRPS1 acts as a scaffold protein in this axis and recruits USP4 and HDAC2 leading to de-ubiquitination and stabilization of HDAC2, deacetylation of H4K16, and transcriptional repression of anti-proliferative genes.
TRPS1, the only reported atypical GATA transcription factor, had been characterized as the first example of a GATA protein with intrinsic transcriptional repression activity [
1]. Our results provide insight into the non-transcription factor function of GATA transcription factors by discovering the scaffolding effect of TRPS1 in USP4-mediated HDAC2 de-ubiquitination and, for the first time, furnish evidence of the physical association and functional link between TRPS1, USP4, and HDAC2.
TRPS1 is co-amplified with
MYC in breast carcinomas with an increased proliferation rate [
41], and silencing
TRPS1 reduces proliferation of BT474 cells [
23]. Also, HDAC2 knockdown in breast cancer cells leads to inhibition of proliferation [
42] and USP4 knockout results in the retarded growth of mouse embryonic fibroblasts (MEF) [
20]. Our working model suggests that TRPS1 recruits USP4 to stabilize HDAC2 repressing the expression of
AES,
Casp7,
PERP, and
ZW10 to confer tumor growth. Exogenous expression of
AES suppresses the growth of LNCaP prostate cancer cells, while knockdown of
AES promotes cell growth [
43]. Inhibition or knockdown of
CASP7 impairs the growth of breast cancer cells [
40]. Deficiency of
PERP has been shown to promote tumor growth [
44], whereas
ZW10 is essential in mitotic checkpoint control [
45]. These scenarios fit well with our working model that TRPS1 recruits USP4 to stabilize HDAC2 and represses expression of
AES,
Casp7,
PERP, and
ZW10 to confer tumor growth. It has been reported that TRPS1 represses the expression of RUNX2 [
46] and ZEB2 [
47]. Furthermore, reduced metastatic spread of triple negative breast cancer cells by TRPS1 has also been described [
7]. How TRPS1 contributes to cancer metastasis needs to be further investigated. Nevertheless, our observations extend current knowledge of the importance of TRPS1 function in carcinogenesis by deciphering the TRPS1-UPS4-HDAC2 regulatory axis and uncovering how TRPS1 contributes to tumor growth.
Global loss of H4K16ac and H4K20me3 is a common marker of human cancer [
48]. H4K16ac plays a critical role in the maintenance of active gene transcription, and its loss is important in the epigenetic silencing of some tumor suppressor genes in cancer [
49]. H4K16ac has been shown to be a specific target of HDAC2 [
16]. Our study has provided evidence that TRPS1, USP4, and HDAC2 are functionally connected through complex formation and that HDAC2 regulates gene transcription by deacetylating H4K16ac.
The ubiquitin system is critical in maintaining protein stability and level. So far, E3 ubiquitin ligase RLIM [
50], Mcl-1 ubiquitin ligase E3 (MULE, also named ARF-BP-1) [
51], and recently reported de-ubiquitinase USP4 [
22] were documented to be involved in regulation of HDAC2 stability by the ubiquitin-proteasome system. However, we found that silencing of neither
RLIM29 nor
MULE affected HDAC2 protein levels (data not shown). The specific mechanism of HDAC2 ubiquitination by ubiquitin ligases needs to be further investigated. Nevertheless, our observation that TRPS1 recruits USP4 to de-ubiquitinate HDAC2 extends the current knowledge on the regulation of HDAC2 stability by the ubiquitin system, contributing to tumor growth. An important regulatory step to counter the outcome of ubiquitination is by removing ubiquitin from ubiquitinated proteins by de-ubiquitinases [
52]. Several studies have reported the importance of de-ubiquitination in stabilizing oncoproteins. For example, USP1 de-ubiquitinates and stabilizes two critical DNA repair proteins, FANCD2 and PCNA, and is involved in Fanconi leukemia [
52,
53]; USP9x de-ubiquitates and stabilizes the pro-survival protein MCL1 [
54]; USP37 is a de-ubiquitinase that regulates the cell cycle by de-ubiquitinating cyclin A [
55] and c-MYC [
56]. Thus, de-ubiquitinases are believed to represent alternative targets in the ubiquitin system for cancer therapies [
57]. USP4, a ubiquitin-specific protease, was proposed to be a potential oncogene for decades [
19]. Our observation that USP4 is recruited by TRPS1 to de-ubiquitinate HDAC2 and silence USP4, resulting in inhibition of tumor cell growth by TRPS1, is consistent with these notions elucidating the underlying molecular details of the oncogenic function of the TRPS1/HDAC2/USP4 axis in tumor growth.
Acknowledgements
We thank all members of Prof. Chen’s laboratory for valuable discussions.